维拉帕米二甲双胍联合用药对高血压合并Ⅱ型糖尿病患者降压及降糖作用临床观察(1)
第1页 |
参见附件(1925KB,3页)。
【摘要】 目的 观察维拉帕米二甲双胍联合用药对高血压合并2型糖尿病(diabetes mellitus,DM)患者降压及降糖作用。方法 将129例高血压合并2型DM患者分为2组,维拉帕米治疗组98例,对照组31例。(1)维拉帕米治疗组:盐酸维拉帕米缓释胶囊180 mg/d,二甲双胍750~1 500 mg/d,缬沙坦80~160 mg/d,阿司匹林100 mg/d;(2)对照组,缬沙坦80~160 mg/d,盐酸维拉帕米缓释胶囊180 mg/d,阿司匹林100 mg/d;(3)血压观测:受试患者早7:00及晚22:00,每日测量2次,记录收缩压(SBP)及舒张压(DBP)。结果 ①二甲双胍2周后收缩压及舒张压与治疗前比较明显下降,4,6周后血压降到正常范围,治疗后比较差异具有显著性(P<0.01);②对照组治疗6周后自身比较差异有显著性(P<0.01),但血压未降到正常范围;③两组治疗6周后比较差异具有显著性(P<0.01),维拉帕米治疗组明显优于对照组;④维拉帕米治疗组治疗12周后复查TC、TG、LDL明显下降,治疗后差异有显著性(P<0.05),HDL治疗后升高为(2.73±0.17),治疗后差异有显著性改善(P<0.05),维拉帕米治疗组明显优于对照组。结论 维拉帕米与二甲双胍联合用药对高血压合并2型糖尿病(DM)患者具有良好的降压效果及降糖作用。
【关键词】 维拉帕米;二甲双胍联合用药治疗;高血压合并2型DM
Clinical observation on Verapamil combined Metformin to treathypertensive patients with Type 2 Diabetes Mellitus for decompression and regulates blood sugar level
LIU Li-biao,ZHU Jing-sheng,LU Wei-hua.
Licheng hospital,Guangdong,Zengcheng 511300,China
【Abstract】 Objective To observe blood pressure lowering effect and the blood glucose lowering effect on the combination of Verapamil and Metformin therapy for hypertensive patients with type 2 diabetes mellitus (diabetes mellitus,DM). Methods 129 cases of hypertension in patients with type 2 DM were divided into two groups,Verapamil treatment group,98 cases in the control group 31 cases. (1) Verapamil treatment groups: Verapamil hydrochloride sustained-release capsules 180 mg/d,Metformin 750 ~ 1 500 mg/d,Valsartan 80~160 mg/d,A Division horses Lin 100 mg/d,(2) control group,Valsartan 80~160 mg/d,Verapamil hydrochloride sustained-release capsules 180 mg/d,Aspirin 100 mg/d. (3) Blood pressure observation: Subjects in patients as early as 7:00 and 22:00 evening,measured two times a day and record systolic blood pressure (SBP) and diastolic blood pressure (DBP). Results ① Metformin 2 weeks after the systolic and diastolic blood pressure decreased significantly compared with those before treatment,4,6 weeks after the blood pressure dropped to normal range after treatment,the difference was significant (P<0 ......
您现在查看是摘要介绍页,详见PDF附件(1925KB,3页)。